Skip to content

Prospective study on the outcome after the distal tears of Stanford type B aortic dissections were sealed

Prospective study on the outcome after the distal tears of Stanford type B aortic dissections were sealed

Status
Recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-OCC-14005570
Enrollment
Unknown
Registered
2014-06-03
Start date
2014-08-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type B aortic dissection

Interventions

the intervention group :early close the distal fissure of type B aortic dissection
observation group:conservative observation

Sponsors

Shanghai sixth people's hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: (1)Aged 18-80, gender is not limited; (2)The aorta CTV diagnosis in the research center confirmed the indications of TEVAR(Thoracic Endovascular Aortic Repair) surgery for Stanford type B aortic dissection. During the operation, aortic angiography was performed to detect the position of main fissure distance of left subclavian artery opening is 1cm or more. The placement of covered stent does not affect the blood flow patency of left subclavian artery and left common carotid artery. (3)In the operation underwent aortic angiography to find obvious distal fissure. (4)Be able to provide written informed consent.

Exclusion criteria

Exclusion criteria: (1)Younger than 18 years of age or older than 80 years old; (2)Patients not found obvious distal tear entry underwent aortic angiography during the operation; (3)The position of main fissure distance of left subclavian artery opening is less than 1cm; (4)Complicated with malignant tumor or other serious diseases or life expectancy is less than 6 months. (5)Asymptomatic myocardial infarction occurred in the past 3 months, or unstable angina attack is greater than or equal to three times in the past 1 month, or serious heart failure that drugs is difficult to control. (6)Complicated with severe respiratory insufficiency (PO2 less than 60 mmHg, namely 8.0Kpa; or PCO2 more than 50mmHg, namely 6.5Kpa (7).Complicated with severe renal insufficiency, creatinine is greater than or equal to 200 umol/L; (8)And severe liver diseases, such as acute or chronic hepatitis, cirrhosis, or cereal third transaminase (ALAT) lifts up to 3 times normal limit. (9)Cerebral hemorrhage or large area cerebral infarction occurred in the last 2 months.

Design outcomes

Primary

MeasureTime frame
thrombosis in the false lumen;Re-operation rate and broken rate;

Secondary

MeasureTime frame
Complications;

Countries

China

Contacts

Public ContactJun Zhao
junnzhao@126.com+86 18930177581

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026